Home

Windgepeitscht Wiederherstellung managen nature medicine crispr einfach Konsens Wunder

Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research: Molecular Therapy - Methods & Clinical Development
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research: Molecular Therapy - Methods & Clinical Development

Nature Medicine on Twitter:
Nature Medicine on Twitter: "#CRISPR–Cas9-induced DNA damage triggers p53 to limit the efficiency of #geneediting in immortalized human retinal pigment epithelial cells: https://t.co/Ofc8akirQF… https://t.co/jA1qViiOE7"

CRISPR, one of the biggest science stories of the decade, explained - Vox
CRISPR, one of the biggest science stories of the decade, explained - Vox

CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine

A new research revealed that the CRISPR–Cas9 genome editing technique may increase cancer risk - Biotech Advisers
A new research revealed that the CRISPR–Cas9 genome editing technique may increase cancer risk - Biotech Advisers

New CRISPR genome-editing system can target disease-causing genetic variations – Harvard Gazette
New CRISPR genome-editing system can target disease-causing genetic variations – Harvard Gazette

First CRISPR editing trial results assuage safety concerns
First CRISPR editing trial results assuage safety concerns

PDF) The CRISPR tool kit for genome editing and beyond
PDF) The CRISPR tool kit for genome editing and beyond

Kill Switch for CRISPR Could Make Gene Editing Safer - Scientific American
Kill Switch for CRISPR Could Make Gene Editing Safer - Scientific American

Four U.S. CRISPR Trials Editing Human DNA to Research New Treatments | Science | Smithsonian Magazine
Four U.S. CRISPR Trials Editing Human DNA to Research New Treatments | Science | Smithsonian Magazine

CRISPR gene editing - Wikipedia
CRISPR gene editing - Wikipedia

p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine

Developing CRISPR/CAS9 technologies for research and medicine - MedCrave online
Developing CRISPR/CAS9 technologies for research and medicine - MedCrave online

Untangling the CRISPR cancer scare
Untangling the CRISPR cancer scare

CRISPR algorithm predicts how well gene editing will work - Scope
CRISPR algorithm predicts how well gene editing will work - Scope

CRISPR: gene editing is just the beginning : Nature News & Comment
CRISPR: gene editing is just the beginning : Nature News & Comment

Nature journal retracts controversial CRISPR paper after authors admit results may be wrong – Retraction Watch
Nature journal retracts controversial CRISPR paper after authors admit results may be wrong – Retraction Watch

Nature Medicine》基因编辑工具增加致癌隐患- 生物通
Nature Medicine》基因编辑工具增加致癌隐患- 生物通

Focus on CRISPR tools and therapies | Nature Biotechnology
Focus on CRISPR tools and therapies | Nature Biotechnology

Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL
Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL

CRISPR-Cas 9 corrects genetic defects in mice
CRISPR-Cas 9 corrects genetic defects in mice

Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy | Nature Medicine
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy | Nature Medicine

CRISPR-Edited Cells Linked to Cancer Risk in 2 Studies - Scientific American
CRISPR-Edited Cells Linked to Cancer Risk in 2 Studies - Scientific American

Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors
Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors

First Trial of CRISPR-Edited T cells in Lung Cancer: Trends in Molecular Medicine
First Trial of CRISPR-Edited T cells in Lung Cancer: Trends in Molecular Medicine